Steven P. Piccoli

1.6k total citations · 1 hit paper
29 papers, 1.0k citations indexed

About

Steven P. Piccoli is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Steven P. Piccoli has authored 29 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Immunology. Recurrent topics in Steven P. Piccoli's work include Advanced Biosensing Techniques and Applications (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Biosimilars and Bioanalytical Methods (7 papers). Steven P. Piccoli is often cited by papers focused on Advanced Biosensing Techniques and Applications (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Biosimilars and Bioanalytical Methods (7 papers). Steven P. Piccoli collaborates with scholars based in United States, Italy and Germany. Steven P. Piccoli's co-authors include Michael D. Cole, Elizabeth J. Keath, G L Shen-Ong, Lowell H. Ericsson, F. Descalzi Cancedda, Milton J. Schlesinger, Kenneth A. Walsh, Ralph Bradshaw, Peter A. Neumann and Perry G. Caimi and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Steven P. Piccoli

26 papers receiving 937 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Novel myc oncogene RNA from abortive immunoglobulin-gene recombination in mouse plasmacytomas

1982 416 citations Steven P. Piccoli et al. profile →

Peers

Countries citing papers authored by Steven P. Piccoli

Since Specialization

Citations

This map shows the geographic impact of Steven P. Piccoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven P. Piccoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven P. Piccoli more than expected).

Fields of papers citing papers by Steven P. Piccoli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven P. Piccoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven P. Piccoli. The network helps show where Steven P. Piccoli may publish in the future.

Co-authorship network of co-authors of Steven P. Piccoli

This figure shows the co-authorship network connecting the top 25 collaborators of Steven P. Piccoli. A scholar is included among the top collaborators of Steven P. Piccoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven P. Piccoli. Steven P. Piccoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Urinary Kidney Injury Biomarker Profiles in Healthy Individuals and After Nephrotoxic and Ischemic Injury 2025 ·Clinical Pharmacology & Therapeutics ·Sushrut S. Waikar, Robin Mogg, Amanda F. Baker, György Frendl, Michael J. Topper, Scott Adler, Stefan Sultana, (unknown), Nicholas M. P. King, Steven P. Piccoli, (unknown), (unknown), Irene Nunes, Frank D. Sistare	4
2	Considerations for Drug Development Biomarker Assays in the Clinical Laboratory 2023 ·Bioanalysis ·Mark E. Arnold, John Allinson, Steven P. Piccoli	0
3	Vodobatinib, a potent, orally bioavailable brain-penetrating inhibitor of c-Abl as a potential neuroprotective agent for treatment of Parkinson disease 2023 ·Parkinsonism & Related Disorders ·Ryan R. Walsh, Steven P. Piccoli, (unknown), (unknown), Damon Love, Orest Hurko, Siu‐Long Yao, V. D. Ramanathan, (unknown)	0
4	Plasma and cerebrospinal fluid pharmacokinetics of vodobatinib, a neuroprotective c-Abl tyrosine kinase inhibitor for the treatment of Parkinson's disease 2023 ·Parkinsonism & Related Disorders ·Ryan R. Walsh, Nitin K. Damle, (unknown), Steven P. Piccoli, (unknown), Damon Love, Siu‐Long Yao, (unknown), Orest Hurko	17
5	Identification of hnRNP-A1 as a pharmacodynamic biomarker of type I PRMT inhibition in blood and tumor tissues 2020 ·Scientific Reports ·(unknown), Timothy W. Sikorski, Francesca Zappacosta, Craig D. Wagner, Rocío Montes de, Matthew Szapacs, Roland S. Annan, Yan Liu, Charles F. McHugh, Helai P. Mohammad, Steven P. Piccoli, Caretha L. Creasy	9
6	Biomarker Assay Validation 2018 ·Bioanalysis ·Steven P. Piccoli, Fabio Garofolo	10
7	Development and Validation of Electrochemiluminescence Assays to Measure Free and Total sSLAMF7 in Human Serum in the Absence and Presence of Elotuzumab 2016 ·The AAPS Journal ·Jennifer Postelnek, Robert Neely, Michael Robbins, Carol Gleason, Jon E. Peterson, Steven P. Piccoli	5
8	Development and Fit-for-Purpose Validation of a Soluble Human Programmed Death-1 Protein Assay 2015 ·The AAPS Journal ·Yan G. Ni, Xiling Yuan, John A. Newitt, Jon E. Peterson, Carol Gleason, (unknown), (unknown), Virginie Lafont, Frank Marsilio, Robert Neely, Binodh DeSilva, Steven P. Piccoli	9
9	Anti-Peg Antibody Bioanalysis: A Clinical Case Study with Peg-Ifn-λ-1A and Peg-Ifn-α2A in Naive Patients 2015 ·Bioanalysis ·Heather Myler, Matthew Hruska, Subasree Srinivasan, Elizabeth Cooney, George Kong, Robert Dodge, Murli Krishna, Jie Zhu, (unknown), Carol Gleason, Steven P. Piccoli, Binodh DeSilva	28
10	Targeting an Acid Labile Aspartyl–Prolyl Amide Bond as A Viable Alternative to Trypsin Digestion to Generate A Surrogate Peptide for LC–MS/MS Analysis 2014 ·Bioanalysis ·Eliza N. Fung, (unknown), (unknown), Steven P. Piccoli, Yan Zhang, Binodh DeSilva, Mark E. Arnold, Alexander Kozhich	6
11	Measuring Biotherapeutics with Endogenous Counterparts and Pre-Existing Antibodies: an Interferon Case Study 2014 ·Bioanalysis ·Heather Myler, (unknown), Jie Zhu, (unknown), Steven P. Piccoli	6
12	Conjugated Critical Reagent Characterization for Ligand-Binding Assays: Using Maldi-TOF-MS as an Orthogonal Tool to Assess Assay Performance 2014 ·Bioanalysis ·(unknown), Steven P. Piccoli	16
13	PhRMA Survey of Pharmacogenomic and Pharmacodynamic Evaluations: What Next? 2012 ·Clinical Pharmacology & Therapeutics ·(unknown), Nadine Cohen, Amelia Warner, Catalina López-Correa, Sharada L. Truter, Amir Snapir, Steven P. Piccoli, (unknown), (unknown), Lois M. Hinman, (unknown)	7
14	Roux-en-Y Gastric Bypass Corrects Hyperinsulinemia Implications for the Remission of Type 2 Diabetes 2011 ·The Journal of Clinical Endocrinology & Metabolism ·Melissa Reed, Walter J. Pories, William H. Chapman, John R. Pender, (unknown), Hisham A. Barakat, Timothy P. Gavin, Tom Green, (unknown), Donghai Zheng, Nigel P. Shankley, Lynn Yieh, David Polidori, Steven P. Piccoli, (unknown), G. Lynis Dohm	94
15	Optimization of Rolling‐Circle Amplified Protein Microarrays for Multiplexed Protein Profiling 2003 ·BioMed Research International ·(unknown), Zhimin Zhou, (unknown), Hong Lü, (unknown), Dhavalkumar D. Patel, Stephen F. Kingsmore, Steven P. Piccoli	48
16	Clinical Evaluation of the Elecsys Total Prostate-specific Antigen Assay on the Elecsys 1010 and 2010 Systems 2002 ·Clinical Chemistry ·Alexander Haese, (unknown), Steven P. Piccoli, Lori J. Sokoll, Alan W. Partin, Daniel W. Chan	6
17	Rolling Circle Amplification Improves Sensitivity in Multiplex Immunoassays on Microspheres 2002 ·Clinical Chemistry ·Michael C. Mullenix, (unknown), William J. Feaver, (unknown), Martin Sorette, (unknown), (unknown), Steven P. Piccoli	9
18	DNA dose and sequence dependence in sperm-mediated gene transfer 2000 ·Molecular Reproduction and Development ·Ilaria Sciamanna, Steven P. Piccoli, Laura Barberi, Germana Zaccagnini, Anna Rosa Magnano, Roberto Giordano, (unknown), (unknown), R Lorenzini, Corrado Spadafora	28
19	Differential induction of stromelysin mRNA by bovine articular chondrocytes treated with interferon‐γ and interleukin‐1α 1993 ·Journal of Cellular Physiology ·Joseph Quintavalla, R A Berg, Andrew J. Beavis, Steven P. Piccoli, John Rediske, Markku Kurkinen, Richard A. Patrick, Fredika M. Robertson	6
20	Amino acid sequence of Escherichia coli alkaline phosphatase. 1981 ·Proceedings of the National Academy of Sciences ·Ralph Bradshaw, F. Descalzi Cancedda, Lowell H. Ericsson, Peter A. Neumann, Steven P. Piccoli, Milton J. Schlesinger, (unknown), Kenneth A. Walsh	149

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact